CIMT 2022: Report on the 19th Annual Meeting of the Association for Cancer Immunotherapy

The 19th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Europe’s cancer immunotherapy meeting, was the first in-person event organized by CIMT since the beginning of the COVID-19 pandemic. As a hybrid event from May 10–12, the meeting attracted 920 academic and clinical professio...

Descripción completa

Detalles Bibliográficos
Autores principales: Berger, Peer Andre, Freitag, Janina, Linkenbach, Sophie-Christin, Merz, Lukas, Schork, Maik, Thevissen, Sophia, Yildiz, Ikra, Beck, Jan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Immunotherapeutics – Meeting Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746370/
https://www.ncbi.nlm.nih.gov/pubmed/36222759
http://dx.doi.org/10.1080/21645515.2022.2124785
_version_ 1784849342423629824
author Berger, Peer Andre
Freitag, Janina
Linkenbach, Sophie-Christin
Merz, Lukas
Schork, Maik
Thevissen, Sophia
Yildiz, Ikra
Beck, Jan D.
author_facet Berger, Peer Andre
Freitag, Janina
Linkenbach, Sophie-Christin
Merz, Lukas
Schork, Maik
Thevissen, Sophia
Yildiz, Ikra
Beck, Jan D.
author_sort Berger, Peer Andre
collection PubMed
description The 19th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Europe’s cancer immunotherapy meeting, was the first in-person event organized by CIMT since the beginning of the COVID-19 pandemic. As a hybrid event from May 10–12, the meeting attracted 920 academic and clinical professionals from over 40 countries, who met to discuss the latest advances in cancer immunology and immunotherapy research. This report summarizes the highlights of CIMT2022.
format Online
Article
Text
id pubmed-9746370
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-97463702022-12-14 CIMT 2022: Report on the 19th Annual Meeting of the Association for Cancer Immunotherapy Berger, Peer Andre Freitag, Janina Linkenbach, Sophie-Christin Merz, Lukas Schork, Maik Thevissen, Sophia Yildiz, Ikra Beck, Jan D. Hum Vaccin Immunother Immunotherapeutics – Meeting Report The 19th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Europe’s cancer immunotherapy meeting, was the first in-person event organized by CIMT since the beginning of the COVID-19 pandemic. As a hybrid event from May 10–12, the meeting attracted 920 academic and clinical professionals from over 40 countries, who met to discuss the latest advances in cancer immunology and immunotherapy research. This report summarizes the highlights of CIMT2022. Taylor & Francis 2022-10-12 /pmc/articles/PMC9746370/ /pubmed/36222759 http://dx.doi.org/10.1080/21645515.2022.2124785 Text en © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Immunotherapeutics – Meeting Report
Berger, Peer Andre
Freitag, Janina
Linkenbach, Sophie-Christin
Merz, Lukas
Schork, Maik
Thevissen, Sophia
Yildiz, Ikra
Beck, Jan D.
CIMT 2022: Report on the 19th Annual Meeting of the Association for Cancer Immunotherapy
title CIMT 2022: Report on the 19th Annual Meeting of the Association for Cancer Immunotherapy
title_full CIMT 2022: Report on the 19th Annual Meeting of the Association for Cancer Immunotherapy
title_fullStr CIMT 2022: Report on the 19th Annual Meeting of the Association for Cancer Immunotherapy
title_full_unstemmed CIMT 2022: Report on the 19th Annual Meeting of the Association for Cancer Immunotherapy
title_short CIMT 2022: Report on the 19th Annual Meeting of the Association for Cancer Immunotherapy
title_sort cimt 2022: report on the 19th annual meeting of the association for cancer immunotherapy
topic Immunotherapeutics – Meeting Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746370/
https://www.ncbi.nlm.nih.gov/pubmed/36222759
http://dx.doi.org/10.1080/21645515.2022.2124785
work_keys_str_mv AT bergerpeerandre cimt2022reportonthe19thannualmeetingoftheassociationforcancerimmunotherapy
AT freitagjanina cimt2022reportonthe19thannualmeetingoftheassociationforcancerimmunotherapy
AT linkenbachsophiechristin cimt2022reportonthe19thannualmeetingoftheassociationforcancerimmunotherapy
AT merzlukas cimt2022reportonthe19thannualmeetingoftheassociationforcancerimmunotherapy
AT schorkmaik cimt2022reportonthe19thannualmeetingoftheassociationforcancerimmunotherapy
AT thevissensophia cimt2022reportonthe19thannualmeetingoftheassociationforcancerimmunotherapy
AT yildizikra cimt2022reportonthe19thannualmeetingoftheassociationforcancerimmunotherapy
AT beckjand cimt2022reportonthe19thannualmeetingoftheassociationforcancerimmunotherapy

Ejemplares similares